- ►ascopubs.org [PDF] A Grothey, MM Sugrue, DM Purdie, W Dong, D … - Journal of Clinical Oncology, 2008 - jco.ascopubs.org Jean-Philippe Spano, Dominique Costagliola, Christine Katlama, Nicolas Mounier,
Eric Oksenhendler, and David Khayat From the Service d'Oncologie Médicale and
Service de Maladies Infectieuses et Tropicales, Assistance Publique Hôpi- ... Cited by 49 - Related articles - All 4 versions
- ►jcojournal.org KJ Vogel, DP Atchley, J Erlichman, KR … - Journal of Clinical Oncology, 2007 - jcojournal.org Purpose The BRCAPRO model, used to predict a family's likelihood of carrying a
BRCA1 or BRCA2 mutation, was designed using mutation frequencies of white and
Ashkenazi Jewish populations, and may not be applicable to other ... Cited by 13 - Related articles - All 4 versions
- ►prsjournal.com AC Antoniou, R Hardy, L Walker, DG Evans, A … - British Medical Journal, 2008 - jmg.bmj.com Objectives: Genetic testing for the breast and ovarian cancer susceptibility
genes BRCA1 and BRCA2 has important implications for the clinical management of
people found to carry a mutation. However, genetic testing is expensive and ... Cited by 8 - Related articles - All 6 versions
- ►ascopubs.org AW Kurian, GD Gong, NM Chun, MA Mills, AD … - Journal of Clinical Oncology, 2008 - jco.ascopubs.org Purpose There are established differences in breast cancer epidemiology between
Asian and white individuals, but little is known about hereditary breast cancer
in Asian populations. Although increasing numbers of Asian individuals are ... Cited by 6 - Related articles - All 6 versions
- ►ascopubs.org D Huo, RT Senie, M Daly, SS Buys, S … - Journal of Clinical Oncology, 2009 - jco.ascopubs.org Purpose BRCAPRO, a BRCA mutation carrier prediction model, was developed on the
basis of studies in individuals of Ashkenazi Jewish and European ancestry. We
evaluated the performance of the BRCAPRO model among clinic-based minority ... Cited by 4 - Related articles - All 4 versions
D Huo, OI Olopade - JAMA, 2007 - Am Med Assoc More than 10 years after BRCA1 and BRCA2 were discovered as major breast cancer
susceptibility genes, the medical community is just beginning to get a glimpse
of how germline mutations in these genes might be distributed among racial/ ... Cited by 3 - Related articles - BL Direct - All 2 versions
- ►oxfordjournals.org SR Cummings, JA Tice, S Bauer, WS Browner, … - JNCI Journal of the National Cancer Institute, 2009 - jnci.oxfordjournals.org Methods: We systematically reviewed prospective studies about models and sex
hormone levels to assess breast cancer risk and used meta-analysis with random
effects models to summarize the predictive accuracy of breast density. We ... Cited by 5 - Related articles - All 11 versions
AW Kurian, GD Gong, EM John, A Miron, A … - Cancer Epidemiology Biomarkers & Prevention, 2009 - AACR Since the identification of the BRCA1 and BRCA2 cancer susceptibility genes,
predictive models have been developed to identify individuals likely to carry
inherited deleterious BRCA mutations. These models assign a patient a ... Cited by 2 - Related articles - All 3 versions
ES Iversen Jr, G Parmigiani, S Chen - Journal of the American Statistical Association, 2008 - 万方数据资源系统 We describe a method for evaluating an ensemble of predictive models given a
sample of observations comprising the model predictions and the outcome event
measured with error. Our formulation allows us to simultaneously estimate ... Related articles - All 4 versions
LS Acheson - Family History and Improving Health Program and … - consensus.nih.gov 31 Research Challenges in Assessing Risk With Family History Louise S. Acheson,
MD, MS Collecting Family History Feasible methods of systematic family history
collection are a prerequisite for research that validates risk algorithms ... Related articles - View as HTML - All 2 versions
